Stopping or continuing chronic antihypertensive therapy during hospitalization
Journal of Internal Medicine · 2026
DOI: 10.1111/joim.70093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Internal Medicine, 2026. Verfasst von Ziv Ribak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine F, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, I…. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension, Hospitalization, Withholding Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Elevated blood pressure is common among hospitalized patients, but the effects of withholding chronic antihypertensive therapy during hospitalization remain unclear.
Objectives
To assess the association between continuation versus discontinuation of chronic antihypertensive medications during hospitalization and short‐ and long‐term outcomes.
Methods
This retrospective propensity score–matched cohort study included adults (≥18 years) with chronic hypertension hospitalized in eight Clalit Health Services hospitals in Israel from January 2014 to May 2024. Eligible patients had received at least one antihypertensive medication continuously for 6 months before admission. Discontinuation was defined as omission of ≥1 chronic medication during hospitalization. Outcomes included in‐hospital and 90‐day acute kidney injury (AKI), myocardial injury, stroke, and all‐cause mortality.
Results
After 1:1 propensity matching, 82,230 patients were analyzed (50,070 internal medicine; 32,160 surgical). In internal medicine departments, discontinuation was associated with higher risk of in‐hospital AKI (OR, 1.23; 95% CI, 1.16–1.30), 90‐day AKI (OR, 1.19; 95% CI, 1.14–1.24), in‐hospital mortality (OR, 2.69; 95% CI, 2.47–2.94), and 90‐day mortality (OR, 1.81; 95% CI, 1.72–1.90). In surgical departments, discontinuation was linked to in‐hospital myocardial injury (OR, 1.26; 95% CI, 1.10–1.44) but not AKI. Results were consistent across subgroups, including infection‐related admissions.
Conclusions
Discontinuing chronic antihypertensive therapy during hospitalization was associated with increased risks of AKI and mortality. These findings suggest that withholding antihypertensive therapy is unlikely to confer benefit and may be harmful.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine F, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
- Department of Internal Medicine H, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
- Clinical Research Center, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
ORCID-Profile: Jacob David Miller
Zitieren
APA
Ribak, Z., Miller, J. D., Burrack, N., Novack, V., & Abuhasira, R. (2026). Stopping or continuing chronic antihypertensive therapy during hospitalization. Journal of Internal Medicine. https://doi.org/10.1111/joim.70093
Vancouver
Ribak Z, Miller JD, Burrack N, Novack V, Abuhasira R. Stopping or continuing chronic antihypertensive therapy during hospitalization. Journal of Internal Medicine. 2026. doi:10.1111/joim.70093
BibTeX
@article{Ribak2026,
author = {Ribak, Ziv and Miller, Jacob David and Burrack, Nitzan and Novack, Victor and Abuhasira, Ran},
title = {Stopping or continuing chronic antihypertensive therapy during hospitalization},
journal = {Journal of Internal Medicine},
year = {2026},
doi = {10.1111/joim.70093}
}
EUVIMED